Imidazopyridines
Medchemexpress LLC CXCR7 modulator 1 (compound 25) | 2231812-31-8 | 99.5% | 914.07 | C48H57F2N7O7S | 100 MG
CXCR7 modulator 1 is a potent, orally bioavailable peptoid-hybrid small molecule that modulates the chemokine receptor CXCR7 (reported Ki = 9 nM). It is intended for research use in studies of GPCR signaling and immunology/inflammation.
- Potent CXCR7 modulator with reported Ki of 9 nM.
- Orally bioavailable peptoid-hybrid small molecule.
- Peptoid-hybrid scaffold suitable for medicinal chemistry studies.
- High purity (99.5%) for research applications.
- Molecular weight 914.07, molecular formula C48H57F2N7O7S.
- Suitable for GPCR signaling and immunology or inflammation research.
Chembridge Corporation 3H-IMIDAZO 4,5-B PYRIDINE-2-TH
3H-imidazo[4,5-b]pyridine-2-thiol; CAS: 29448-81-5
Medchemexpress LLC Cxcr7 modulator 1 | 2231812-31-8 | 99.5% | 914.07 | C48H57F2N7O7S | 50 MG
CXCR7 modulator 1 is a potent, orally bioavailable peptoid-hybrid modulator of the chemokine receptor CXCR7 with an in vitro Ki of 9 nM. It is supplied for preclinical biochemical and pharmacological research into CXCR7 signaling and ligand-receptor interactions.
- Potent CXCR7 affinity (Ki = 9 nM)
- Orally bioavailable chemical scaffold suitable for in vivo dosing studies
- High reported purity for reliable experimental results
- Supplied as a solid suitable for formulation and analytical work
- Available in multiple small research sizes for dose-ranging studies
![Accela Chembio Inc Imidazo[1 | 2-a]pyridine-3-carboxylic Acid | 1g | 6200-60-8 | MFCD01720458 | 97+% | Shelf Life: 1260 Days | Light Sensitive](https://assets.fishersci.com/TFS-Assets/CCG/product-images/VN00116475-SY004048-1G.PNG-250.jpg)
Accela Chembio Inc Imidazo[1 | 2-a]pyridine-3-carboxylic Acid | 1g | 6200-60-8 | MFCD01720458 | 97+% | Shelf Life: 1260 Days | Light Sensitive
Imidazo[1 | 2-a]pyridine-3-carboxylic Acid | 1g | 6200-60-8 | MFCD01720458 | 97+% | Shelf Life: 1260 Days | Light Sensitive
Medchemexpress LLC Az084 | 929300-19-6 | 99.7% | 10 MG
AZ084 is a potent, selective, orally active CCR8 allosteric antagonist provided for preclinical research. The compound is characterized with manufacturer-reported purity, molecular data, solubility protocols for in vitro and in vivo use, and recommended storage conditions to support pharmacology and immunology studies.
- Potent CCR8 allosteric antagonist with reported Ki ≈ 0.9 nM.
- High purity reported at 99.65%.
- Molecular weight 434.57 g/mol; formula C26H34N4O2.
- Soluble in DMSO (250 mg/mL) and formulatable for in vivo dosing protocols.
- Appearance: light yellow to yellow solid.
- Storage recommendations: powder at -20°C (long term) and in solvent at -80°C for best stability.
- Intended for research use only; not for human or clinical use.
eMolecules 106730-54-5 | Olprinone | MFCD25541649 | 1g
Pharmablock | 4-amino-23-difluorobenzonitrile | 25mg | 721310889 | PBTYC0222 | 112279-71-7 | MFCD09030642 | 154.120 | C7H4F2N2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Az084 | 929300-19-6 | 99.7% | 5 MG
AZ084 is a selective, orally active CCR8 allosteric antagonist for research use. It demonstrates sub-nanomolar potency and is supplied as a high-purity solid suitable for in vitro and in vivo pharmacology studies. Solubility and storage guidance are provided to support experimental formulation and handling.
- Selective CCR8 allosteric antagonist with Ki ≈ 0.9 nM.
- High purity suitable for cellular and pharmacological assays.
- Supplied as a milligram-scale solid for in vitro and in vivo use.
- Highly soluble in DMSO; formulation examples provided for dosing.
- Recommended storage conditions for powder and solutions to preserve stability.
- Intended as a research tool for immunology and inflammation studies.